Cargando…
The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma
Drug repurposing is currently an important approach for accelerating drug discovery and development for clinical use. Hepatocellular carcinoma (HCC) presents drug resistance to chemotherapy, and the prognosis is poor due to the existence of liver cancer stem-like cells. In this study, we investigate...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392272/ https://www.ncbi.nlm.nih.gov/pubmed/26061710 http://dx.doi.org/10.18632/oncotarget.4307 |
_version_ | 1783229413199970304 |
---|---|
author | Chen, Jia-Jie Cai, Nan Chen, Guan-Zhong Jia, Chang-Chang Qiu, Dong-Bo Du, Cong Liu, Wei Yang, Yang Long, Zi-Jie Zhang, Qi |
author_facet | Chen, Jia-Jie Cai, Nan Chen, Guan-Zhong Jia, Chang-Chang Qiu, Dong-Bo Du, Cong Liu, Wei Yang, Yang Long, Zi-Jie Zhang, Qi |
author_sort | Chen, Jia-Jie |
collection | PubMed |
description | Drug repurposing is currently an important approach for accelerating drug discovery and development for clinical use. Hepatocellular carcinoma (HCC) presents drug resistance to chemotherapy, and the prognosis is poor due to the existence of liver cancer stem-like cells. In this study, we investigated the effect of the neuroleptic agent pimozide to inhibit stem-like cell maintenance and tumorigenicity in HCC. Our results showed that pimozide functioned as an anti-cancer drug in HCC cells or stem-like cells. Pimozide inhibited cell proliferation and sphere formation capacities in HCC cells by inducing G0/G1 phase cell cycle arrest, as well as inhibited HCC cell migration. Surprisingly, pimozide inhibited the maintenance and tumorigenicity of HCC stem-like cells, particularly the side population (SP) or CD133-positive cells, as evaluated by colony formation, sphere formation and transwell migration assays. Furthermore, pimozide was found to suppress STAT3 activity in HCC cells by attenuating STAT3-dependent luciferase activity and down-regulating the transcription levels of downstream genes of STAT3 signaling. Moreover, pimozide reversed the stem-like cell tumorigenic phenotypes induced by IL-6 treatment in HCC cells. Further, the antitumor effect of pimozide was also proved in the nude mice HCC xenograft model. In short, the anti-psychotic agent pimozide may act as a novel potential anti-tumor agent in treating advanced HCC. |
format | Online Article Text |
id | pubmed-5392272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53922722017-04-21 The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma Chen, Jia-Jie Cai, Nan Chen, Guan-Zhong Jia, Chang-Chang Qiu, Dong-Bo Du, Cong Liu, Wei Yang, Yang Long, Zi-Jie Zhang, Qi Oncotarget Research Paper Drug repurposing is currently an important approach for accelerating drug discovery and development for clinical use. Hepatocellular carcinoma (HCC) presents drug resistance to chemotherapy, and the prognosis is poor due to the existence of liver cancer stem-like cells. In this study, we investigated the effect of the neuroleptic agent pimozide to inhibit stem-like cell maintenance and tumorigenicity in HCC. Our results showed that pimozide functioned as an anti-cancer drug in HCC cells or stem-like cells. Pimozide inhibited cell proliferation and sphere formation capacities in HCC cells by inducing G0/G1 phase cell cycle arrest, as well as inhibited HCC cell migration. Surprisingly, pimozide inhibited the maintenance and tumorigenicity of HCC stem-like cells, particularly the side population (SP) or CD133-positive cells, as evaluated by colony formation, sphere formation and transwell migration assays. Furthermore, pimozide was found to suppress STAT3 activity in HCC cells by attenuating STAT3-dependent luciferase activity and down-regulating the transcription levels of downstream genes of STAT3 signaling. Moreover, pimozide reversed the stem-like cell tumorigenic phenotypes induced by IL-6 treatment in HCC cells. Further, the antitumor effect of pimozide was also proved in the nude mice HCC xenograft model. In short, the anti-psychotic agent pimozide may act as a novel potential anti-tumor agent in treating advanced HCC. Impact Journals LLC 2015-05-27 /pmc/articles/PMC5392272/ /pubmed/26061710 http://dx.doi.org/10.18632/oncotarget.4307 Text en Copyright: © 2017 Chen et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Chen, Jia-Jie Cai, Nan Chen, Guan-Zhong Jia, Chang-Chang Qiu, Dong-Bo Du, Cong Liu, Wei Yang, Yang Long, Zi-Jie Zhang, Qi The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma |
title | The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma |
title_full | The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma |
title_fullStr | The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma |
title_full_unstemmed | The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma |
title_short | The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma |
title_sort | neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392272/ https://www.ncbi.nlm.nih.gov/pubmed/26061710 http://dx.doi.org/10.18632/oncotarget.4307 |
work_keys_str_mv | AT chenjiajie theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT cainan theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT chenguanzhong theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT jiachangchang theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT qiudongbo theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT ducong theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT liuwei theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT yangyang theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT longzijie theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT zhangqi theneurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT chenjiajie neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT cainan neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT chenguanzhong neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT jiachangchang neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT qiudongbo neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT ducong neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT liuwei neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT yangyang neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT longzijie neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma AT zhangqi neurolepticdrugpimozideinhibitsstemlikecellmaintenanceandtumorigenicityinhepatocellularcarcinoma |